Humana’s outlook isn’t great, but performance in the fourth quarter was a bit better than expected. Shares were up after the ...

Barclays analyst Andrew Mok raised the firm’s price target on Humana (HUM) to $270 from $255 and keeps an Equal Weight rating on the shares.

Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its ...

The dip came after Humana released its 2024 end of year and fourth quarter earnings, which projected an annual profit of ...

Humana posted a $693 million loss in the fourth quarter of 2024, a notable increase from its $541 million loss in the ...

Humana will make investments to improve its Medicare Advantage Star Ratings, Chief Financial Officer Celeste Mellet said.

RBC Capital analyst Ben Hendrix maintained a Buy rating on Humana (HUM – Research Report) yesterday and set a price target of $283.00. The ...

Humana posted higher-than-expected quarterly revenue, but gave an unexpectedly weak outlook for the year now under way. The Louisville, Ky., health insurer company logged a fourth-quarter loss of $693 ...

"You're not going to uproot 10,000 people and suddenly snap your fingers and have them somewhere else," said Jim Rechtin, the president & CEO of Humana.

Humana Inc.’s stock dipped 0.5% early Tuesday, after the health insurer and managed-care company’s quarterly loss widened.